Seeking Alpha

Valeant Pharmaceuticals (VRX) raised its offer for ISTA Pharmaceuticals (ISTA) to $7.50/share...

Valeant Pharmaceuticals (VRX) raised its offer for ISTA Pharmaceuticals (ISTA) to $7.50/share from an initial $6.50/share, and set a target price of $8.50/share subject to a week of due diligence, according to an ISTA statement. ISTA officials say they're considering the revised offer but are also in talks with other companies. (previously)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs